2026-04-18T03:42:52Zhttps://recercat.cat/oai/requestoai:recercat.cat:10459.1/645182024-12-05T22:27:03Zcom_2072_3622col_2072_479130
RECERCAT
author
Carmona, Andrés
author
Agüera, Maria L.
author
Luna-Ruiz, Carlos
author
Buendía, Paula
author
Calleros-Basilio, Laura
author
García-Jerez, Andrea
author
Rodríguez-Puyol, Manuel
author
Arias, Manuel
author
Arias-Guillen, Marta
author
Arriba, Gabriel de
author
Ballarín, José
author
Bernis, Carmen
author
Fernández i Giráldez, Elvira
author
García-Rebollo, Sagrario
author
Mancha, Javier
author
Peso, Gloria del
author
Pérez, Estefanía
author
Poch, Esteban
author
Portolés, José M.
author
Rodríguez-Puyol, Diego
author
Sánchez-Villanueva, Rafael
author
Sarró, Felipe
author
Torres, Armando
author
Martín-Malo, Alejandro
author
Aljama, Pedro
author
Ramírez, Rafael
author
Carracedo, Júlia
2024-12-05T22:27:03Z
2024-12-05T22:27:03Z
2018-06-15T11:02:28Z2018-06-15T11:02:28Z2017-04-012018-06-15T11:02:28Z
http://hdl.handle.net/10459.1/64518
Patients with Stage 5 chronic kidney disease who are on hemodialysis (HD) remain in a chronic inflammatory state, characterized by the accumulation of uremic toxins that induce endothelial damage and cardiovascular disease (CVD). Our aim was to examine microvesicles (MVs), monocyte subpopulations, and angiopoietins (Ang) to identify prognostic markers in HD patients with or without diabetes mellitus (DM). A total of 160 prevalent HD patients from 10 centers across Spain were obtained from the Biobank of the Nephrology Renal Network (Madrid, Spain): 80 patients with DM and 80 patients without DM who were matched for clinical and demographic criteria. MVs from plasma and several monocyte subpopulations (CD142+/CD16+, CD14+/CD162+) were analyzed by flow cytometry, and the plasma concentrations of Ang1 and Ang2 were quantified by ELISA. Data on CVD were gathered over the 5.5 yr after these samples were obtained. MV level, monocyte subpopulations (CD14+/CD162+ and CD142+/CD16+), and Ang2-to-Ang1 ratios increased in HD patients with DM compared with non-DM patients. Moreover, MV level above the median (264 MVs/µl) was associated independently with greater mortality. MVs, monocyte subpopulations, and Ang2-to-Ang1 ratio can be used as predictors for CVD. In addition, MV level has a potential predictive value in the prevention of CVD in HD patients. These parameters undergo more extensive changes in patients with DM.Support for this work was provided by Plan Nacional de IDi Proyectos de Investigación en Salud of Instituto de Salud Carlos III (ISCIII)–Subdirección General de Evaluación, Fondos de desarrollo regional (FEDER; PI11/01536, PI12/01489, PI14/00806, PI15/01785); Junta de Andalucía grants (P010-CTS-6337, P11-CTS-7352); and Fundación Nefrológica. P. Buendía, A.
Carmona, and C. Luna-Ruiz are fellows from Consejería de Innovacion, Ciencia y Empresa, Junta de Andalucía.
(c) The American Physiological Society, 2017 info:eu-repo/semantics/openAccess
Chronic kidney disease
Cardiovascular disease
Diabetes mellitus
Markers of endothelial damage in patients with chronic kidney disease on hemodialysis
info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion